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Incident OA was more common in women and in those with
longer inter-assessment time or longer time since initial menis-
cectomy. Subjects with progressive OA had significantly higher
BMI, longer inter-assessment time, and longer time since initial
meniscectomy than non-progressors (Table 1).
Conclusions: A previous meniscectomy is associated with a
very high risk of both prevalent and incident radiographic knee
OA. In the 3-10 year time window studied here, some 18-32 years
after the index meniscal surgery, there is a substantial number
of both incident and progressive knee OA cases. These large
numbers highlight the important role of meniscal integrity in OA
development. They also warrant increased efforts towards better
prevention and treatment of meniscal lesions in both the normal
knee and the knee with incipient OA. Persons with previous
meniscectomy may represent a useful model for studies on OA
development and treatment.
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SYSTEMIC EXPOSURE TO INORGANIC SULFATES
AFTER ORAL ADMINISTRATION OF GLUCOSAMINE AS
HYDROCHLORIDE ALONE OR IN COMBINATION WITH
CHONDROITIN SULFATE OR AS CRYSTALLINE
GLUCOSAMINE SULFATE IN MAN
S. Persiani, D. Paganini, L. Lavizzari, R. Chistè, L.C. Rovati
Rottapharm, Monza, Italy
Purpose: The effects of glucosamine on knee osteoarthritis
symptoms were revisited by two recent randomised, controlled
trials: the GUIDE study confirmed the efficacy of prescription glu-
cosamine sulfate 1500 mg once-a-day, but the NIH-sponsored
GAIT failed to show any benefit of nutraceutical glucosamine
hydrochloride 500 mg t.i.d. These results may depend on glu-
cosamine peak plasma levels that are much lower with the GAIT
formulation (Arthritis Rheum 2005, 9 Suppl:1342 and ACR meet-
ing 2005: Late breaking abstract L13). However, it has been
suggested that sulfates may also contribute to the effects of glu-
cosamine. Actually, the combination of glucosamine hydrochlo-
ride and chondroitin sulfate was effective in an exploratory anal-
ysis of GAIT in the subgroup of patients with moderate-to-severe
pain. Therefore, the aim of this preliminary study was to as-
sess the systemic exposure to sulfates after administration of
glucosamine sulfate or glucosamine hydrochloride alone or in
combination with chondroitin sulfate, by determining the urinary
excretion of inorganic sulfates.
Methods: Four healthy volunteers (2 males, 2 females) received
for 5 consecutive days either crystalline glucosamine sulfate
1500 mg once-a-day, or the combination of glucosamine hy-
drochloride 500 mg and chondroitin sulfate 400 mg t.i.d. in a
randomised cross-over fashion. In a parallel study arm, four
volunteers (2 males, 2 females) were administered only glu-
cosamine hydrochloride 500 mg t.i.d. The urinary excretion of
inorganic sulfate was determined over 24 hours at baseline and
during the last day of administration by ion exchange chromatog-
raphy, with a limit of quantitation of 0.01 mM.
Results: The mean (SD) baseline urinary excretion of sulfate
in the cross-over study was 12.9±4.5 mM/24 h. After both
glucosamine sulfate and the combination of glucosamine hy-
drochloride with chondroitin sulfate, the urinary excretion of sul-
P331 – Table 1. Tibial Cartilage Thickness and Muscle Strength Following a 6 Month Exercise Intervention
Group Cartilage Thickness (mm) Change in Overall Muscle Strength (%)
Medial Tibia (n=14) Lateral Tibia (n=17)
Pre Post Pre Post
PRT 1.41 ± 0.26 1.36 ± 0.23 1.72 ± 0.30 1.72 ± 0.24 52±27*
Sham 1.25 ± 0.20 1.26 ± 0.19 1.68 ± 0.37 1.71 ± 0.35 6±16*
* P = 0.001 between group difference in change score
fate was higher in all subjects and averaged 17.9±5.2 mM/24
h and 18.4±3.8 mM/24 h, respectively. The mean increase was
5.0±1.8 mM/24 h and 5.6±2.5 mM/24 h, respectively, i.e. simi-
lar between groups and corresponding to 40-50% over baseline
levels. As expected, glucosamine hydrochloride induced no or
negligible changes in sulfate excretion, reflecting only physiolog-
ical fluctuations and averaging 2.0±2.2 mM/24 h, or 13% over
baseline.
Conclusions: Glucosamine hydrochloride provides no systemic
exposure to inorganic sulfate. Conversely, the combination of
glucosamine hydrochloride with chondroitin sulfate and the stan-
dard glucosamine sulfate formulation produce similar exposure
to inorganic sulfates, thus possibly explaining some of the con-
tradictory findings within GAIT and in comparison with GUIDE.
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Purpose: Osteoarthritis (OA) is one of the most common
musculo-skeletal disorders, affecting 9.6% of men and 18.0%
of women ≥ 60 years of age worldwide. The aim of the study is
to investigate the effect of high intensity progressive resistance
training (PRT) on articular cartilage morphology in women with
knee OA. As the study is ongoing, the aim of this abstract is
to present preliminary data on the primary outcome, cartilage
thickness.
Methods: Our cohort consisted of women over 40 years of age
with knee OA, according to the American College of Rheumatol-
ogy criteria.
Primary outcome was blinded measurement of cartilage mor-
phology via a 3 Tesla MRI of the tibiofemoral joint (repetition time
= 34ms, echo time = 9ms, acquisition time = 10min, flip angle
= 25°, slice thickness = 1.4mm, in-plane resolution = 0.312mm).
Medial (MT) and lateral tibial (LT) articular cartilage was seg-
mented using Chondrometrics software (CV = 2.2% MT, 2.1%
LT). The primary outcome was cartilage thickness. Secondary
outcomes included cartilage volume, proportion denuded area,
muscle strength, BMI, and WOMAC score.
Subjects were randomised into a PRT or sham-exercise group.
Both groups trained 3/week for 6 months. The PRT group trained
at 80% of their peak strength, using Keiser pneumatic resistance
machines, and were prescribed 3% increments in load per ses-
sion. Exercises included knee extension and flexion, leg press,
plantarflexion, hip abduction and adduction. Sham group trained
on the same equipment except hip adduction, but without added
resistance or progression.
An intention-to-treat analysis was used. T-test or Wilcoxon signed
rank non-parametric test was used for comparing groups at base-
line, and Kruskal-Wallis test and ANCOVA adjusted for relevant
covariates were used to assess changes over time. Data ex-
pressed as mean±SD.
S180 Poster Presentations
Results: 41 subjects have completed baseline assessments
and started the training intervention (Age: 65±8 years, BMI:
33.1±6.8kg/m2, Total WOMAC Score: 33±15). Of those, 17
have completed the training intervention. Due to imaging artifact
in the medial compartment, articular cartilage from 14 medial
tibias was segmented. All lateral tibias were included. There was
no significant difference between groups for cartilage thickness
as shown in the table, or any other clinical variables at baseline.
However, medial cartilage volume (P= 0.039) was significantly
lower in the sham group; and lateral denuded area (P=0.02) was
significantly lower in the PRT group at baseline.
Cartilage thickness (P=0.334 MT, P=0.445 LT), volume (P=0.419
MT, P=0.699 LT) and denuded area (P=0.739 MT, P=0.563 LT)
did not change significantly following the training intervention.
Overall strength increased significantly in the PRT group com-
pared to the sham group following the training intervention.
Conclusions: These interim results suggest cartilage thickness,
volume and denuded area were not significantly different be-
tween groups following the training intervention. Overall muscle
strength increased significantly in the PRT group compared to
the sham group over time. Completion of the full complement
of subjects in this ongoing trial will allow further analysis of the
relationship between anabolic exercise and cartilage morphology
in OA.
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GLUCOSAMINE SULFATE IMPROVES QUALITY OF LIFE
OF KNEE OSTEOARTHRITIS PATIENTS IN THE
GLUCOSAMINE UNUM IN DIE EFFICACY (GUIDE) TRIAL
G. Herrero-Beaumont1, J. Branco2
1Fundacion Jimenez Diaz-Capio, Madrid, Spain, 2For the
GUIDE investigators, CHLO, EPE/H.E. Moniz, Lisboa, Portugal
Purpose: The GUIDE trial showed the efficacy of the prescrip-
tion glucosamine sulfate formulation on the symptoms of knee
osteoarthritis (Arthritis Rheum 2005;52, 9 Suppl:1203). The aim
of the present study was to assess its effects on Quality of Life
in the GUIDE patient cohort.
Methods: GUIDE was a multicenter, prospective, randomised,
double-blind, parallel-group trial. Patients with knee osteoarthritis
(ACR criteria) received double-dummy oral glucosamine sulfate
soluble powder 1500mg once-a-day, or acetaminophen 1000mg
tablets t.i.d., or placebo for 6 months. Quality of Life was as-
sessed by the SF-36 questionnaire in 296 patients at random-
ization and repeated after 6 months. The primary analysis was
conducted on the changes in the SF-36 Mental Component
Score (MCS, assessing the domains Mental Health, Role Emo-
tional, Social Functioning) and Physical Component Score (PCS,
with domains Bodily Pain, Role Physical, Physical Functioning,
Vitality, General Health, the latter two being included also in the
calculation of the MCS). Changes in each domain were sec-
ondary endpoints. GLM-ANOVA was used with the Dunnet’s test
adjusting for the comparisons of each active vs placebo, in ITT
by the LOCF approach. Effect sizes vs placebo were calculated
as the difference between mean changes standardized on the
pooled SD. The Pearson test assessed the correlation between
the changes in the SF-36 and those in the previously reported
primary (Lequesne index) and secondary (WOMAC index) symp-
tom outcomes in the trial.
P332 – Table 1
Placebo N=96 Acetaminophen N=100 Glucosamine Sulfate N=100
Baseline  6 months Baseline  6 months Baseline  6 months
SF-36 PCS (mean±SD) 33.3±8.3 1.7±10.3 34.2±9.0 4.2±9.1 32.7±9.3 6.7±10.4*
SF-36 MCS (mean±SD) 53.3±11.4 0.7±11.0 50.0±13.2 0.3±11.8 50.9±13.0 0.7±10.6
*P=0.001 vs Placebo: Difference=5.0 (95% CI: 1.9 to 8.2). Effect Size=0.49 (0.20 to 0.77)
Results: Glucosamine sulfate showed an improvement in all
PCS domains of the SF-36, that was significant vs placebo
for Bodily Pain (P=0.014), Role Physical (P=0.006) and Gen-
eral Health (P=0.031). The difference on the aggregate PCS
was therefore highly significant, with a good effect size (Table
1). There were no significant improvements in the MCS, thus
excluding direct psychological effects. Acetaminophen was not
significantly different from placebo in any of the analyses.
There was a highly significant correlation (P<0.01) between the
improvements in the SF-36 PCS and those previously reported
in the Lequesne index (r =0.58) and WOMAC total (r =0.56), pain
(r =0.51) and function (r =0.56) scales, respectively.
Conclusions: Treatment for 6 months with glucosamine sulfate
1500mg once-a-day improves Quality of Life in knee osteoarthri-
tis by favorably affecting the physical components of well-being,
in a way that is highly correlated with its efficacy on pain and
function as assessed by disease specific measures.
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IS THE BONE MINERAL DENSITY DIFFERENT BETWEEN
PATIENTS WITH RAPIDLY DESTRUCTIVE AND SLOWLY
HIP OSTEOARTHRITIS?
P. Richette, S. Lamy, E. Vicaut, M.-C. de Vernejoul, P. Orcel,
T. Bardin
Hôpital Lariboisière, Paris, France
Purpose: Rapidly destructive osteoarthritis of the hip (RDA) is
an uncommon form of hip OA that is seen mostly in elderly
postmenopausal women. Recent discovery of subchondral insuf-
ficiency fracture that precedes destruction of the femoral head
suggests a role for ostopenia during rapid destruction of the hip
joint. The aim of our work was to compare the bone mineral
density (BMD) between patients with rapidly destructive hip OA
(RDA) and slowly progressive hip OA.
Methods: This prospective cross sectional case-control study
was conducted in 26 patients with RDA. Patients were recruited
from our institution between 2000 and 2006. RAD was defined
by the following criteria: severe hip pain; annual rate of joint
space loss >2 mm; erythrocyte sedimentation rate <20 mm/1st
h. MRI of the hip was performed in 15 patients with RDA. Bone
mineral density was measured at the femoral neck and lumbar
spine (L1-L4) using dual-energy X-ray absorptiometry (Hologic).
For comparison, BMD was measured in 33 women with slowly
hip OA who were scheduled for primary total hip arthroplasty.
Comparisons between the two groups of patients were made
using student t test for all variables. Two-sided significance level
was fixed at 5%. All tests were made using SAS software version
9.13 (from SAS Institute).
Results: The patients with rapidly destructive hip OA (80%
women and 20%men) did not differ from control in age (74.9 ±
9.9 vs 74.7 ± 8.8; p=0.92) and BMI (26.3 ± 4.3 vs 26.3 ± 5;
p=0.96). In patients with RDA, mean BMD was 1.0 ±0.2 g/cm2
at the lumbar spine (Tscore: -0.6 ±1.3) and 0.7±0.1 g/cm2 at the
femoral neck (Tscore:-1.5±1.1). In controls, mean BMD was 1.0
±0.2 g/cm2 at the lumbar spine (Tscore: -0.8 ±1.5)(p=0.67) and
0.8±0.2 g/cm2 at the femoral neck (Tscore:-1.4±1.4)(p=0.40).
In three patients (20%), evidence of subchondral insufficiency
fracture was shown on MR imaging.
Conclusions: The results of our study do not support a role for
